NO20016184L - Frakoblingsoverflate - Google Patents

Frakoblingsoverflate

Info

Publication number
NO20016184L
NO20016184L NO20016184A NO20016184A NO20016184L NO 20016184 L NO20016184 L NO 20016184L NO 20016184 A NO20016184 A NO 20016184A NO 20016184 A NO20016184 A NO 20016184A NO 20016184 L NO20016184 L NO 20016184L
Authority
NO
Norway
Prior art keywords
disconnection surface
cells
disconnection
proliferate
detach
Prior art date
Application number
NO20016184A
Other languages
English (en)
Other versions
NO20016184D0 (no
Inventor
Robert Short
David Haddow
Sheila Macneil
Original Assignee
Celltran Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celltran Ltd filed Critical Celltran Ltd
Publication of NO20016184D0 publication Critical patent/NO20016184D0/no
Publication of NO20016184L publication Critical patent/NO20016184L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068—General culture methods using substrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
    • C12N2533/92—Amnion; Decellularised dermis or mucosa
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2539/00—Supports and/or coatings for cell culture characterised by properties
    • C12N2539/10—Coating allowing for selective detachment of cells, e.g. thermoreactive coating

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Dermatology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Microbiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Liquid Crystal (AREA)
  • Glass Compositions (AREA)
  • Centrifugal Separators (AREA)
  • Saccharide Compounds (AREA)
  • Water Treatment By Sorption (AREA)
  • Image-Pickup Tubes, Image-Amplification Tubes, And Storage Tubes (AREA)
NO20016184A 1999-06-23 2001-12-18 Frakoblingsoverflate NO20016184L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9914616.9A GB9914616D0 (en) 1999-06-23 1999-06-23 Attachment surface
PCT/GB2000/002297 WO2000078928A2 (en) 1999-06-23 2000-06-23 Surface for cell culture

Publications (2)

Publication Number Publication Date
NO20016184D0 NO20016184D0 (no) 2001-12-18
NO20016184L true NO20016184L (no) 2002-02-21

Family

ID=10855861

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20016184A NO20016184L (no) 1999-06-23 2001-12-18 Frakoblingsoverflate

Country Status (15)

Country Link
EP (1) EP1185621B1 (no)
JP (2) JP4748699B2 (no)
CN (1) CN1357039A (no)
AT (1) ATE458807T1 (no)
AU (1) AU776839B2 (no)
CA (1) CA2375557C (no)
DE (1) DE60043888D1 (no)
DK (1) DK1185621T3 (no)
GB (1) GB9914616D0 (no)
HK (1) HK1047294B (no)
IL (2) IL146933A0 (no)
NO (1) NO20016184L (no)
NZ (1) NZ516064A (no)
WO (1) WO2000078928A2 (no)
ZA (1) ZA200110319B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9925016D0 (en) * 1999-10-23 1999-12-22 Univ Sheffield Binding surface
CA2444518A1 (en) * 2001-04-17 2002-10-24 University Of Sheffield Biomaterials comprising a melanocyte stimulating hormone (msh), and method of forming
WO2003030959A1 (en) * 2001-10-06 2003-04-17 Btg International Limited Corneal repair device
WO2003030958A1 (en) * 2001-10-06 2003-04-17 Celltran Limited Corneal graft
WO2003035850A1 (en) * 2001-10-26 2003-05-01 Celltran Limited Cell transfer substrate
WO2004018654A2 (en) * 2002-08-22 2004-03-04 Celltran Limited Cell culture surface
EP1635782A1 (de) 2003-05-24 2006-03-22 JUVENA (International) AG Gewebekulturmedien als bestandteil von kosmetika
US8288118B2 (en) 2007-09-19 2012-10-16 Becton, Dickinson And Company Method of analyzing various surface chemistries for culturing a given cell line
PL2628490T3 (pl) * 2012-02-01 2014-09-30 Bioenergy Capital Ag Matryca do zasiedlania komórkami
EP2623133B1 (de) * 2012-02-01 2014-04-02 Bioenergy Capital AG Implant-matrix aus einem Polymergemisch

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5928472A (ja) * 1982-08-09 1984-02-15 Koken:Kk 細胞培養用基質およびこの基質を用いた細胞培養・分離法
WO1987005038A1 (en) * 1986-02-17 1987-08-27 Commonwealth Scientific And Industrial Research Or Implantable materials

Also Published As

Publication number Publication date
ZA200110319B (en) 2003-07-22
HK1047294B (zh) 2011-02-18
AU776839B2 (en) 2004-09-23
IL146933A0 (en) 2002-08-14
IL146933A (en) 2008-03-20
DK1185621T3 (da) 2010-04-26
EP1185621A2 (en) 2002-03-13
DE60043888D1 (de) 2010-04-08
GB9914616D0 (en) 1999-08-25
NO20016184D0 (no) 2001-12-18
NZ516064A (en) 2003-11-28
JP2011125351A (ja) 2011-06-30
CA2375557A1 (en) 2000-12-28
EP1185621B1 (en) 2010-02-24
CA2375557C (en) 2012-02-21
AU5546400A (en) 2001-01-09
CN1357039A (zh) 2002-07-03
JP2003503318A (ja) 2003-01-28
ATE458807T1 (de) 2010-03-15
HK1047294A1 (en) 2003-02-14
WO2000078928A2 (en) 2000-12-28
WO2000078928A3 (en) 2001-07-12
JP4748699B2 (ja) 2011-08-17

Similar Documents

Publication Publication Date Title
EP1648397A4 (en) EX VIVO EXPANSION OF PROGENITOR CELLS AND STEM CELLS FOR THE TREATMENT OF ORGAN DISEASES DERIVED FROM THE ENDODERM
IL210618A (en) Cell cultures containing isolated and multiplied human cells other than embryonic and germ cells, pharmaceutical preparations containing them, methods of preparation, and methods for identifying modulators and differentiation factors.
ATE349976T1 (de) Mikrostruktur-stentstruktur
AU2002366380A1 (en) Pluripotent stem cells derived without the use of embryos or fetal tissue
IL148512A0 (en) Methods for making recombinant proteins using apoptosis inhibitors
AU2003259055A8 (en) Cell and tissue culture device
TR200102648T2 (tr) Büyümeyi destekleyen bileşimler
DK0839026T3 (da) Micellære polyether-blokcopolymerkompositioner til målretning af biologiske midler
AU6842001A (en) Pluripotent mammalian cells
BR0214029A (pt) Métodos e composições para o uso de células estromais para suportar células tronco embriÈnicas e adultas
TW200516149A (en) Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair
WO2002039948A3 (en) Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants
EP1416044A4 (en) CELL CULTURE / TISSUE CULTURE SUPPORT AND CULTURE METHOD
WO2002086073A3 (en) Generation of differentiated tissue from nuclear transfer embryonic stem cells and methods of use
NO20016184L (no) Frakoblingsoverflate
WO2002007749A3 (en) Device providing regulated growth factor delivery for the regeneration of peripheral nerves
ATE514771T1 (de) Haartransplantation
AU2002235168A1 (en) Targeting pluripotent stem cells to tissues
AU2860901A (en) TH1 specific CD4 T cell lines and method for inducing them ex vivo
AU2001283199A1 (en) Methods and compositions for the diagnosis and treatment of brown adipose cell disorders
ZA200202468B (en) Modulation of T cell differentiation for the treatment of T helper cell mediated diseases.
AU6986201A (en) Renal regulatory elements and methods of use thereof
MXPA02002444A (es) Metodo para generar celulas y tejidos inmunocompatibles, utilizando tecnicas de transferencia nuclear.
AU6219100A (en) The use of membranes, cells and tissue from the area postrema to identify therapeutic compounds
UA38572A (uk) Клізма

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application